clinicalomicsprowebdirectory
News
Topics
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Marketplace
Multimedia
Clinical OMICs Live
Virtual Event
Webinars
eBooks
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Search
Advertise
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Lead Generation Campaigns
Email Nurture Campaigns
Custom Content Solutions
About Us
Contact Us
Mary Ann Liebert Publishers
Create a Free Account
Log In
Clinical OMICs – Molecular Diagnostics in Precision Medicine
News
Precision Medicine
PathAI Broadens Diagnostics Portfolio with Poplar Acquisition
Oncology
Mutations from Thiopurines May Cause ALL to Relapse
Translational Research
Autism Spectrum Disorder in Children Linked to Non-Diet-Influenced Features of Gut…
RNA Sequencing
Three-Platform Approach Brings Precision Medicine Closer for Children with Cancer
Precision Medicine
Caribou Biosciences’ IPO Hauls in $304M to Fund Development of Gene-Edited…
Topics
All
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
New Products
Enzymatic Fragmentation Library Preparation Kit
Precision Medicine
PathAI Broadens Diagnostics Portfolio with Poplar Acquisition
Oncology
Mutations from Thiopurines May Cause ALL to Relapse
Translational Research
Autism Spectrum Disorder in Children Linked to Non-Diet-Influenced Features of Gut…
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Marketplace
Multimedia
All
Clinical OMICs Live
Virtual Event
Webinars
eBooks
Virtual Event
From Detection to Testing: Utilizing NGS to Power Precision Medicine
Upcoming Webinars
Early Cancer Recurrence Detection: A Tumor-Informed Approach
eBooks
Unlocking the Cancer Code
Clinical OMICs Live
The GENOME ODYSSEY: Solving Medical Mysteries with Euan Ashley, MD, PhD
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Home
Molecular Dx
Pharmacogenomic Testing
Pharmacogenomic Testing
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pharmacogenomic Testing
New Drug Type Effective Against Medulloblastoma Identified by Pharmacogenomic Screening Method
July 8, 2021
Pharmacogenomic Testing
NorthShore Taps Sema4 in Launch of System-Wide Genomics Program
April 19, 2021
Pharmacogenomic Testing
Clopidogrel (Plavix) is a Safe and Effective Blood Thinner in Patients...
March 19, 2021
Pharmacogenomic Testing
myDNA Merges with Gene by Gene, Uniting Personalized Genetics Pioneers
January 8, 2021
Pharmacogenomic Testing
Pharmacogenetics Research for COVID-19 Drugs Needed to Improve Patient Safety
August 31, 2020
Pharmacogenomic Testing
RxGenomix, Translational Software Ink PGx Partnership
May 12, 2020
Pharmacogenomic Testing
Regeneron, Colorado Center for Personalized Medicine Enter Broad Genetics Research Collaboration
May 11, 2020
Pharmacogenomic Testing
Genomind to Ship Mental Health PGx Test Directly to Patients
March 20, 2020
Pharmacogenomic Testing
Treading with Caution: PGx Test Developers Pursue Dialogue as FDA Maintains...
November 7, 2019
Pharmacogenomic Testing
Genomind Restores Drug Information to PGx Reports, But Only for Physicians
September 23, 2019
Load more
Featured
Treating Ultrarare Diseases, One Patient at a Time
April 9, 2021
Sponsored: Making NGS Actionable—Moving Oncology Beyond ‘One Mutation-One Drug’
June 24, 2021
Hunting for Hereditary Cancers
April 9, 2021
New Products
View More
Enzymatic Fragmentation Library Preparation Kit
July 27, 2021
Direct RNA Amplification Reagents
April 13, 2021
Bioinformatics for Multi-Omics Discovery at Massive Scale
March 15, 2021
Load more
Scroll Up
We use cookies to give you a better experience on clinicalomics.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![CRISPR Therapeutics and Massachusetts General Hospital Cancer Center said they will use CRISPR/Cas9 gene editing to develop novel T cell therapies for blood and solid tumors. [Source: Feng Zhang and Steve Dixo]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1218-218x150.jpeg "Caribou Biosciences’ IPO Hauls in $304M to Fund Development of Gene-Edited Cell Therapies")
![OneOme will expand its RightMed® PGx testing into Canada's retail pharmacy market through a partnership with ProZed Pharmacy Solutions. [Source: iStock/Yuri_Arcurs]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1178-324x160.jpeg "RxGenomix, Translational Software Ink PGx Partnership")
